A citation-based method for searching scientific literature

Yuliya Pylayeva-Gupta, Kyoung Eun Lee, Cristina H Hajdu, George Miller, Dafna Bar-Sagi. Cancer Cell 2012
Times Cited: 397







List of co-cited articles
1674 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
Lauren J Bayne, Gregory L Beatty, Nirag Jhala, Carolyn E Clark, Andrew D Rhim, Ben Z Stanger, Robert H Vonderheide. Cancer Cell 2012
564
53

Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
Carolyn E Clark, Sunil R Hingorani, Rosemarie Mick, Chelsea Combs, David A Tuveson, Robert H Vonderheide. Cancer Res 2007
582
26

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.
Yu Zhu, Brett L Knolhoff, Melissa A Meyer, Timothy M Nywening, Brian L West, Jingqin Luo, Andrea Wang-Gillam, S Peter Goedegebuure, David C Linehan, David G DeNardo. Cancer Res 2014
626
24

Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
23

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Christine Feig, James O Jones, Matthew Kraman, Richard J B Wells, Andrew Deonarine, Derek S Chan, Claire M Connell, Edward W Roberts, Qi Zhao, Otavia L Caballero,[...]. Proc Natl Acad Sci U S A 2013
883
23

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
Jinyang Li, Katelyn T Byrne, Fangxue Yan, Taiji Yamazoe, Zeyu Chen, Timour Baslan, Lee P Richman, Jeffrey H Lin, Yu H Sun, Andrew J Rech,[...]. Immunity 2018
220
23

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
19

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Richard A Moffitt, Raoud Marayati, Elizabeth L Flate, Keith E Volmar, S Gabriela Herrera Loeza, Katherine A Hoadley, Naim U Rashid, Lindsay A Williams, Samuel C Eaton, Alexander H Chung,[...]. Nat Genet 2015
731
18

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.
Richard E Royal, Catherine Levy, Keli Turner, Aarti Mathur, Marybeth Hughes, Udai S Kammula, Richard M Sherry, Suzanne L Topalian, James C Yang, Israel Lowy,[...]. J Immunother 2010
635
18

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
Sunil R Hingorani, Lifu Wang, Asha S Multani, Chelsea Combs, Therese B Deramaudt, Ralph H Hruban, Anil K Rustgi, Sandy Chang, David A Tuveson. Cancer Cell 2005
18

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Gregory L Beatty, Elena G Chiorean, Matthew P Fishman, Babak Saboury, Ursina R Teitelbaum, Weijing Sun, Richard D Huhn, Wenru Song, Dongguang Li, Leslie L Sharp,[...]. Science 2011
18

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Hong Jiang, Samarth Hegde, Brett L Knolhoff, Yu Zhu, John M Herndon, Melissa A Meyer, Timothy M Nywening, William G Hawkins, Irina M Shapiro, David T Weaver,[...]. Nat Med 2016
442
17

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
Timothy M Nywening, Brian A Belt, Darren R Cullinan, Roheena Z Panni, Booyeon J Han, Dominic E Sanford, Ryan C Jacobs, Jian Ye, Ankit A Patel, William E Gillanders,[...]. Gut 2018
151
17

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Stefani Spranger, Riyue Bao, Thomas F Gajewski. Nature 2015
17

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Colin W Steele, Saadia A Karim, Joshua D G Leach, Peter Bailey, Rosanna Upstill-Goddard, Loveena Rishi, Mona Foth, Sheila Bryson, Karen McDaid, Zena Wilson,[...]. Cancer Cell 2016
374
17

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
Daniel Öhlund, Abram Handly-Santana, Giulia Biffi, Ela Elyada, Ana S Almeida, Mariano Ponz-Sarvise, Vincenzo Corbo, Tobiloba E Oni, Stephen A Hearn, Eun Jung Lee,[...]. J Exp Med 2017
707
16

Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.
Rafael Winograd, Katelyn T Byrne, Rebecca A Evans, Pamela M Odorizzi, Anders R L Meyer, David L Bajor, Cynthia Clendenin, Ben Z Stanger, Emma E Furth, E John Wherry,[...]. Cancer Immunol Res 2015
248
16

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
Berna C Özdemir, Tsvetelina Pentcheva-Hoang, Julienne L Carstens, Xiaofeng Zheng, Chia-Chin Wu, Tyler R Simpson, Hanane Laklai, Hikaru Sugimoto, Christoph Kahlert, Sergey V Novitskiy,[...]. Cancer Cell 2014
16

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Dominic E Sanford, Brian A Belt, Roheena Z Panni, Allese Mayer, Anjali D Deshpande, Danielle Carpenter, Jonathan B Mitchem, Stacey M Plambeck-Suess, Lori A Worley, Brian D Goetz,[...]. Clin Cancer Res 2013
301
16

Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
Ingunn M Stromnes, J Scott Brockenbrough, Kamel Izeradjene, Markus A Carlson, Carlos Cuevas, Randi M Simmons, Philip D Greenberg, Sunil R Hingorani. Gut 2014
176
15

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
15

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Andrew D Rhim, Paul E Oberstein, Dafydd H Thomas, Emily T Mirek, Carmine F Palermo, Stephen A Sastra, Erin N Dekleva, Tyler Saunders, Claudia P Becerra, Ian W Tattersall,[...]. Cancer Cell 2014
15

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
Paolo P Provenzano, Carlos Cuevas, Amy E Chang, Vikas K Goel, Daniel D Von Hoff, Sunil R Hingorani. Cancer Cell 2012
15

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.
Jonathan B Mitchem, Donal J Brennan, Brett L Knolhoff, Brian A Belt, Yu Zhu, Dominic E Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica-Worms,[...]. Cancer Res 2013
559
15

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
15

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
15

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
14

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Vinod P Balachandran, Marta Łuksza, Julia N Zhao, Vladimir Makarov, John Alec Moral, Romain Remark, Brian Herbst, Gokce Askan, Umesh Bhanot, Yasin Senbabaoglu,[...]. Nature 2017
434
14

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.
Yaqing Zhang, Ashley Velez-Delgado, Esha Mathew, Dongjun Li, Flor M Mendez, Kevin Flannagan, Andrew D Rhim, Diane M Simeone, Gregory L Beatty, Marina Pasca di Magliano. Gut 2017
141
14


Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
Ela Elyada, Mohan Bolisetty, Pasquale Laise, William F Flynn, Elise T Courtois, Richard A Burkhart, Jonathan A Teinor, Pascal Belleau, Giulia Biffi, Matthew S Lucito,[...]. Cancer Discov 2019
312
14

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.
Eric A Collisson, Anguraj Sadanandam, Peter Olson, William J Gibb, Morgan Truitt, Shenda Gu, Janine Cooc, Jennifer Weinkle, Grace E Kim, Lakshmi Jakkula,[...]. Nat Med 2011
836
13

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Kenneth P Olive, Michael A Jacobetz, Christian J Davidson, Aarthi Gopinathan, Dominick McIntyre, Davina Honess, Basetti Madhu, Mae A Goldgraben, Meredith E Caldwell, David Allard,[...]. Science 2009
13

Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.
Roderik M Kortlever, Nicole M Sodir, Catherine H Wilson, Deborah L Burkhart, Luca Pellegrinet, Lamorna Brown Swigart, Trevor D Littlewood, Gerard I Evan. Cell 2017
191
13

Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
Carmen Guerra, Alberto J Schuhmacher, Marta Cañamero, Paul J Grippo, Lena Verdaguer, Lucía Pérez-Gallego, Pierre Dubus, Eric P Sandgren, Mariano Barbacid. Cancer Cell 2007
758
13

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
Sunil R Hingorani, Emanuel F Petricoin, Anirban Maitra, Vinodh Rajapakse, Catrina King, Michael A Jacobetz, Sally Ross, Thomas P Conrads, Timothy D Veenstra, Ben A Hitt,[...]. Cancer Cell 2003
13

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
13


Cancer-associated stromal fibroblasts promote pancreatic tumor progression.
Rosa F Hwang, Todd Moore, Thiruvengadam Arumugam, Vijaya Ramachandran, Keith D Amos, Armando Rivera, Baoan Ji, Douglas B Evans, Craig D Logsdon. Cancer Res 2008
762
12

IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Giulia Biffi, Tobiloba E Oni, Benjamin Spielman, Yuan Hao, Ela Elyada, Youngkyu Park, Jonathan Preall, David A Tuveson. Cancer Discov 2019
292
12

Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.
Marina Lesina, Magdalena U Kurkowski, Katharina Ludes, Stefan Rose-John, Matthias Treiber, Günter Klöppel, Akihiko Yoshimura, Wolfgang Reindl, Bence Sipos, Shizuo Akira,[...]. Cancer Cell 2011
561
12

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
Jude Canon, Karen Rex, Anne Y Saiki, Christopher Mohr, Keegan Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G Knutson, Neelima Koppada,[...]. Nature 2019
499
12

Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.
Florencia McAllister, Jennifer M Bailey, Janivette Alsina, Christopher J Nirschl, Rajni Sharma, Hongni Fan, Yanique Rattigan, Jeffrey C Roeser, Rachana H Lankapalli, Hao Zhang,[...]. Cancer Cell 2014
214
11

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
11

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.
Gregory L Beatty, Rafael Winograd, Rebecca A Evans, Kristen B Long, Santiago L Luque, Jae W Lee, Cynthia Clendenin, Whitney L Gladney, Dawson M Knoblock, Patrick D Guirnalda,[...]. Gastroenterology 2015
151
11

Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Abasi Ene-Obong, Andrew J Clear, Jennifer Watt, Jun Wang, Rewas Fatah, John C Riches, John F Marshall, Joanne Chin-Aleong, Claude Chelala, John G Gribben,[...]. Gastroenterology 2013
265
11

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
11

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.
Meredith A Collins, Filip Bednar, Yaqing Zhang, Jean-Christophe Brisset, Stefanie Galbán, Craig J Galbán, Sabita Rakshit, Karen S Flannagan, N Volkan Adsay, Marina Pasca di Magliano. J Clin Invest 2012
413
11

Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.
Jung-Eun Jang, Cristina H Hajdu, Caroline Liot, George Miller, Michael L Dustin, Dafna Bar-Sagi. Cell Rep 2017
153
11

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.
Roheena Z Panni, John M Herndon, Chong Zuo, Samarth Hegde, Graham D Hogg, Brett L Knolhoff, Marcus A Breden, Xiaobo Li, Varintra E Krisnawan, Samia Q Khan,[...]. Sci Transl Med 2019
66
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.